Navigation Links
First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
Date:8/27/2007

y lead to the first approval for phenoxodiol," Mr. Naughton said.

In a prior Phase II clinical trial, phenoxodiol was tested in combination with either cisplatin or paclitaxel. Patients with late stage ovarian cancer that had become refractory to platinum or paclitaxel therapy, following multiple courses of chemotherapy, were treated with phenoxodiol and cisplatin or phenoxodiol and paclitaxel, respectively. Of 21 patients in the cisplatin arm there were six partial responders, nine patients with stabilised disease and six patients who had disease progression; of 19 in the paclitaxel arm, there was one complete responder, two partial responders, eleven with stabilised disease and five patients who had disease progression. There were few side effects associated with phenoxodiol, but, as with any investigational drug, there is a possibility of unexpected side effects.

Professor Ignace Vergote, the Principal Investigator at the Leuven site was Chairman of the EORTC Gynaecologic Cancer Group from 1997 to 2003, and still chairs the Protocol Committee of that group. He is currently the President of the International Cancer Society and Immediate Past-President of the European Society of Gynaecologic Oncology.

Women who are interested in participating in the OVATURE trial, or who simply wish to learn more about this study, should visit http://www.OVATUREtrial.com or visit http://clinicaltrials.gov/ (type OVATURE in the search box).

About phenoxodiol: Phenoxodiol is being developed as a therapy for late- stage, chemo-resistant prostate, ovarian and cervical cancers. Phenoxodiol is an investigational drug and, as such, is not commercially available. It is a novel-acting drug that inhibits key pro-survival signalling pathways operating via sphingosine-1-phosphate and Akt. Inhibition of these pathways leads to prevention of phosphorylation of ke
'/>"/>

SOURCE Novogen Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015  Nitin Tandon, M.D., UTHealth ... Memorial Hermann Mischer Neuroscience Institute at ... RNS® System technology into the skull of a ... of seizures – the first time this procedure ... "Epilepsy is a neurological condition that affects ...
(Date:7/6/2015)... July 6, 2015 Flower Orthopedics, the ... the FlowerCube™, announced today that it has received ... for significant expansion of the innovative FlowerCube™ concept ... approval encompasses Flower Orthopedics, entire product line, which ... and lower extremities. Consisting of more than 400 ...
(Date:7/6/2015)... , July 6, 2015 RoundTable Healthcare ... exclusively on the healthcare industry, announced today that ... ("TIDI" or the "Company"). Founded in 1969 in ... once primarily a manufacturer of paper-based barrier products. ... initiatives, TIDI has expanded its product offering to ...
Breaking Medicine Technology:Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4Flower Orthopedics cleared to enter the European Union 2RoundTable Healthcare Partners Acquires TIDI Products 2RoundTable Healthcare Partners Acquires TIDI Products 3
... Sept. 9 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... Triax Pharmaceuticals, LLC announced today the ... strength of tretinoin; Tretin-X 0.0375%, for the treatment of ... that offers a between strength – effective ... hydrating cream vehicle. For those patients already on tretinoin ...
Cached Medicine Technology:Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 2Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 3Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 4Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 5Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 6Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 7Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance 8New, Exclusive Strength: Tretin-X® 0.0375%(tretinoin) Cream 2
(Date:7/6/2015)... ... ... report titled “ Female Hair Loss Needs to be Talked About, Shed Stigma, Experts Say,” ... U.S. will suffer from thinning hair or hair loss . For these 30 million women, ... queen, who was interviewed for the report began losing her hair at age 11 due to ...
(Date:7/6/2015)... ... July 06, 2015 , ... Hundreds of thousands of ... which is why liposuction regularly ranks among the top five most popular cosmetic ... become more than a way to slim down a silhouette for swimsuit season. ...
(Date:7/6/2015)... ... ... doTERRA, the leading global essential oils company, is pleased to announce the ... position as Director of the Hinckley Institute at the University of Utah, a position ... states that he was ready for a new challenge, and out of many potential ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and genomics projects have generated ... to access and use this “Big Data” to improve health and cut costs is ... of the Mount Sinai Health System in New York City. Physicians will have these ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community program in the ... Our Youth and announced a new charity campaign to raise funds in support of ... drug abuse. Livonia Save Our Youth is a coalition created especially to educate and ...
Breaking Medicine News(10 mins):Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3
... study conducted on sexual health and relationships in Ireland ... of Health reveals// that more than half the population of ... sexual intercourse before the legally approved age of consent which ... note that the average age of the first sexual encounter ...
... The dengue virus continued its spread across Uttar Pradesh with ... chikungunya viral disease started showing up// in many areas Monday. ... the state recorded 44 new cases since Saturday. The spread ... ,Chikungunya is on the rise with 16 of the ...
... changes in diet such as decreasing sugar-sweetened beverage consumption, ... salad// could help teens battle weight. ,Cara Ebbeling ... teens -- half were asked to pick non-caloric or ... was delivered to their homes, reported the health portal ...
... Janette Howard ,wife of John Howard ,the prime minister of ... to the public// and media for the first time that ... ,A patron of the National Breast Cancer Centre, she ... the launch of an all important national breast cancer report.,Over ...
... Aricept becomes the first drug to be cleared for treatment ... 13. It had been previously approved// for treating the initial ... upto 6,180 yen on the Tokyo Stock Exchange on Monday ... cure, which affects brain functions of memory and thinking, leading ...
... for sex workers in China had angered the police there.// ... of over 50 sex workers by the Center for Disease ... News. It reported that the local police found the lecture ... their profession on their foreheads this time. Being unable to ...
Cached Medicine News:Health News:Sex Among Teens More Rampant says Irish Reports 2Health News:Small Diet Changes can Help Teens Trim Down 2
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
Introducing Optronics DVMR, the first digital surgical documentation system designed for the microsurgical operating room environment. DVMR accepts images from a variety of high-resolution cameras fo...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: